Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Finasteride 0.5% Once Daily vs Twice Daily in Male Androgenetic Alopecia
TCTR20240816002Phase 3Completed
- Sponsor
- Faculty of Medicine, Srinakharinwirot University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of finasteride in androgenetic alopecia (AGA), sponsored by Faculty of Medicine, Srinakharinwirot University. Started Sep 2024; status: completed.
02
Drugs
finasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20240816002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240816002.